Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study for Testing Safety and Efficacy of the Administration of Blood-Borne Autologous Endothelial Progenitor Cells to Alleviate Anginal Symptoms and Myocardial Ischemia in Patients With Severe Anginal Syndrome

NCT00384514 is registered in ClinicalTrials.gov with TheraVitae Ltd. as lead sponsor.

NCT NCT00384514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00384514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study for Testing Safety and Efficacy of the Administration of Blood-Borne Autologous Endothelial Progenitor Cells to Alleviate Anginal Symptoms and Myocardial Ischemia in Patients With Severe Anginal Syndrome
Lead sponsor
TheraVitae Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2004
Completion date
September 30, 2006
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease